Replies to post #192319 on Anavex Life Sciences Corp (AVXL)

[leaping frog]

Lurking is my specialty. Clued by a poster on another board, maybe Bourbon or Whiskey, don't remember, I became interested in Anavex in early 2015. Share price was $0.17. In July I took an uninterrupted position when the company announced 5 week interim data from the phase 1-A trial.

Motivated by a noxious poster of recent vintage I created my own identity a scant few days ago to get the "ignore" feature. Memo: 5 is not enough.

I am grateful to you stalwarts of the board for sharing so generously the products of your due diligence and the fruits of your acumen (in me lacking) for science, business and finance, investing, technical analysis, und so weiter.

I call out Dad of 3M for special thanks. The reading you assigned in a post on the YMB helped me to maintain confidence in this investment through harrowing times which could have provoked otherwise a neurodegenerative cascade.

dry17, thank you for extending to me the hospitality of the board.

At the annual meeting Dr. Missling said: "2019 will be a year of execution for us. This is the year we execute."

So mote it be.